PARTNERSHIPS

Please reach out to us to discuss partnering opportunities and how together we can build better cell therapies for patients in need across oncology indications (CAR-T, CAR-NK, TCR-T, γδ T cells, TILs, etc), autoimmune indications, and other cell therapy applications (diabetes, etc).

CELL THERAPIES FOR ONCOLOGY

Best-in-class against known targets & first-in-class for novel targets or new modalities.

TREGS FOR AUTOIMMUNE

Regulatory T cell therapies to treat autoimmune diseases. Optimized for therapeutic efficacy and manufacturing.

Waypoint Partnering Areas target identification and prioritization

TARGET ID & PRIORITIZATION

Human genetics-based target ID and prioritization. Allelic series & deep profiling of in vivo phenotypes.